Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hocanalyses of the EPOC trial

被引：0
作者：
Jonathan Calkwood
Bruce Cree
Heidi Crayton
Daniel Kantor
Brian Steingo
Luigi Barbato
Ron Hashmonay
Neetu Agashivala
Kevin McCague
Nadia Tenenbaum
Keith Edwards
机构：
[1] Minneapolis Clinic of Neurology,
[2] University of California San Francisco,undefined
[3] MS Center of Greater Washington,undefined
[4] Neurologique,undefined
[5] Fort Lauderdale MS Center,undefined
[6] Novartis Pharmaceuticals Corporation,undefined
[7] MS Center of Northeastern New York,undefined
来源：
BMC Neurology | / 14卷
关键词：
36-item Short-Form Health Survey (SF-36); Beck Depression Inventory-II (BDI-II); Clinical Global Impressions of Improvement (CGI-I); Fatigue Severity Scale (FSS); Fingolimod; FTY720; Multiple sclerosis; Treatment Satisfaction Questionnaire for Medication (TSQM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 237 条
  • [111] McFarland HF(undefined)undefined undefined undefined undefined-undefined
  • [112] O'Connor PW(undefined)undefined undefined undefined undefined-undefined
  • [113] Sandberg-Wollheim M(undefined)undefined undefined undefined undefined-undefined
  • [114] Thompson AJ(undefined)undefined undefined undefined undefined-undefined
  • [115] Weinshenker BG(undefined)undefined undefined undefined undefined-undefined
  • [116] Wolinsky JS(undefined)undefined undefined undefined undefined-undefined
  • [117] Atkinson MJ(undefined)undefined undefined undefined undefined-undefined
  • [118] Sinha A(undefined)undefined undefined undefined undefined-undefined
  • [119] Hass SL(undefined)undefined undefined undefined undefined-undefined
  • [120] Colman SS(undefined)undefined undefined undefined undefined-undefined
78910111213141516